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Abstract Blood progenitors within the lymph gland, a larval organ that supports hematopoiesis in 
Drosophila melanogaster, are maintained by integrating signals emanating from niche-like cells and 
those from differentiating blood cells. We term the signal from differentiating cells the ‘equilibrium 
signal’ in order to distinguish it from the ‘niche signal’. Earlier we showed that equilibrium signaling 
utilizes Pvr (the Drosophila PDGF/VEGF receptor), STAT92E, and adenosine deaminase-related growth 
factor A (ADGF-A) (Mondal et al., 2011). Little is known about how this signal initiates during 
hematopoietic development. To identify new genes involved in lymph gland blood progenitor 
maintenance, particularly those involved in equilibrium signaling, we performed a genetic screen that 
identified bip1 (bric à brac interacting protein 1) and Nucleoporin 98 (Nup98) as additional regulators 
of the equilibrium signal. We show that the products of these genes along with the Bip1-interacting 
protein RpS8 (Ribosomal protein S8) are required for the proper expression of Pvr.
DOI: 10.7554/eLife.03626.001
Introduction
Similar to vertebrates, blood cell differentiation in Drosophila is regulated in multiple hematopoietic 
environments, which include the head mesoderm of the embryo (Tepass et al., 1994; Lebestky et al., 
2000; Milchanowski et al., 2004), the specialized, tissue-associated microenvironments of the larval 
periphery (e.g, body wall hematopoietic pockets) (Markus et al., 2009; Makhijani et al., 2011), and 
the larval lymph gland, an organ dedicated to the development of blood cells that normally contribute 
to the pupal and adult stages (Rizki, 1978; Shrestha and Gateff, 1982; Lanot et al., 2001; Jung 
et al., 2005). Understanding how blood cell development is regulated in the lymph gland is the pri-
mary goal underlying the work presented here. Differentiating blood cells (hemocytes) of the lymph 
gland are derived from multipotent progenitors (Jung et al., 2005; Mandal et al., 2007; Martinez-
Agosto et al., 2007). These blood progenitors readily proliferate during the early growth phases of 
lymph gland development, which is followed by a period in which many of these cells slow their rate 
of division and are maintained without differentiation in a region termed the medullary zone (MZ, 
Figure 1) (Jung et al., 2005; Mandal et al., 2007). During the same period, other progenitor cells 
begin to differentiate along the peripheral edge of the lymph gland to give rise to a separate cortical 
zone (CZ) (Jung et al., 2005). How progenitor cell maintenance and differentiation are regulated 
during the course of lymph gland development has become a major area of exploration in recent years, 
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the larval stages (Lebestky et al., 2003; Mandal et al., 2007; Owusu-Ansah and Banerjee, 2009; 
Sinenko et al., 2009; Mondal et al., 2011; Mukherjee et al., 2011; Tokusumi et al., 2011; Dragojlovic-
Munther and Martinez-Agosto, 2012; Pennetier et al., 2012; Shim et al., 2012; Sinenko et al., 
2012). Wingless (Wg; Wnt in vertebrates) is expressed by blood progenitor cells in the lymph gland 
and has an important role in promoting their maintenance (Sinenko et al., 2009), and reactive oxygen 
species (ROS) function in these cells to potentiate blood progenitor differentiation both in the context 
of normal development and during oxidative stress (Owusu-Ansah and Banerjee, 2009). Progenitor 
cell maintenance at late developmental stages is also dependent upon Hedgehog (Hh) signaling from 
a small population of cells called the posterior signaling center that functions as a hematopoietic niche 
(PSC) (Lebestky et al., 2003; Jung et al., 2005).
More recently, it has been discovered that the maintenance of lymph gland blood progenitors also 
requires a backward signal arising from the differentiating cells (Mondal et al., 2011). This signal is 
controlled by a novel pathway that combines the function of the receptor tyrosine kinase Pvr and JAK-
independent STAT (STAT92E) activation in differentiating cells, followed by the expression of ADGF-A 
(Figure 1), a secreted enzyme that converts adenosine to inosine (Mondal et al., 2011). Extracellular 
adenosine is a well-established signal in mammalian systems in various contexts, particularly stress 
conditions (Fredholm, 2007; Sheth et al., 2014), and an elevated adenosine level in Drosophila 
causes extensive blood cell proliferation (Dolezal et al., 2005; Mondal et al., 2011). It has been 
demonstrated that differentiating and mature cells express (and are the primary source of) ADGF-A, 
and that its enzymatic activity (which converts adenosine to inosine) is required for progenitor cell 
maintenance (Mondal et al., 2011). As differentiation proceeds, ADGF-A expression (activity) increas-
ingly promotes the maintenance of extant blood progenitors through the reduction of stimulatory 
adenosine. In this way, the differentiating cell population helps balance the progenitor/differentiating 
cell ratio and is the basis for our referring to ADGF-A as an ‘equilibrium signal’.
eLife digest Progenitor cells are cells that can either multiply to make new copies of themselves 
or mature into different specialized cell types—such as blood cells. In the fruit fly Drosophila, new 
blood cells are formed in several different locations, including in an organ called the lymph gland.
In 2011, researchers found that the fate of blood progenitor cells within the lymph gland is 
controlled by signals from two nearby sources—one from specialized, supportive (‘niche’) cells and 
the other from maturing blood cells. The signal from the maturing blood cells ensures that the 
relative amounts of progenitor and maturing blood cells are kept in the right balance. As a result, 
this signaling process has been called ‘equilibrium signaling’.
Questions remain as to how equilibrium signaling is regulated, and how it interacts with signals 
from the niche. To investigate this, Mondal et al.—including some of the researchers involved in the 
2011 work—used various genetic techniques to create Drosophila larvae in which the tissues that 
become blood cells are made visible with fluorescent proteins. This meant that these tissues could 
be examined in live, whole animals by using a microscope. Mondal et al. then searched for the 
Drosophila genes involved in generating new blood cells in the lymph gland—particularly those 
involved in equilibrium signaling. This was done by switching on and off hundreds of genes, one by 
one, in the lymph gland, and any genes that caused changes to the generation of new blood cells 
were then investigated further.
Following these investigations, Mondal et al. focused on three genes—and when each of these 
genes was switched off in maturing blood cells, the result was that fewer progenitor cells remained 
in the lymph gland. This effect was not seen when the genes were switched off in the progenitor or 
the niche cells, which suggested that the genes are likely to be components of the equilibrium 
signaling pathway. Switching off these genes in maturing blood cells also dramatically reduced the 
levels of a protein called Pvr, a key equilibrium signaling protein known from the 2011 study and an 
important player in blood cell development in several species.
How the newly identified genes actually control Pvr protein levels to maintain proper equilibrium 
signaling in the lymph gland remains to be explored. However, this work provides a basis for investigating 
the role of related genes in blood cell development in vertebrate systems, namely humans.
DOI: 10.7554/eLife.03626.002
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Loss of ADGF-A (or STAT or Pvr) from differ-
entiating cells increases extracellular adenosine 
level and thereby increases Adenosine Receptor 
(AdoR) signaling and downstream Protein Kinase 
A (PKA) activity in progenitors, which causes 
these cells to proliferate (Dolezal et al., 2005; 
Mondal et al., 2011). PKA is a central regulator 
of progenitor maintenance because it integrates 
input from both the equilibrium signal (ADGF-A) 
and the niche signal (Hh). PKA mediates the con-
version of the transcriptional regulator Cubitus 
interruptus (Ci, a homolog of vertebrate Gli) from 
its full length form (Ci155), required for progenitor 
maintenance (Mandal et al., 2007), to a cleaved 
form (Ci75) that promotes proliferation. Signaling 
by Hh inhibits PKA and promotes Ci155 stabiliza-
tion whereas adenosine/AdoR signaling activates 
PKA and promotes Ci75 conversion. Thus, both Hh 
(the niche signal) and ADGF-A (the equilibrium 
signal which removes adenosine) limit PKA activity 
and promote progenitor cell maintenance.
Although niche and equilibrium signaling are 
both clearly important, details of their regulation 
and interaction are less clear. Thus, we performed 
a loss-of-function genetic screen to identify new 
genes involved in lymph gland blood progenitor 
maintenance, particularly those involved in equilib-
rium signaling. In this study, we report the results 
of this screen and the identification of three genes, 
bip1, RpS8, and Nup98, as new components of the 
equilibrium signaling pathway.
Results and discussion
HHLT-gal4 and its use for whole-
animal genetic screening during 
hematopoietic development
Unlike the adult eye or wing, analysis of internal 
larval tissues such as the lymph gland requires 
laborious dissection and processing. To circum-
vent this barrier to genetic screening, we gener-
ated a line of flies termed the Hand-Hemolectin 
Lineage Traced-gal4 line (HHLT-gal4 UAS-2XEGFP, 
Figure 2A; see ‘Materials and methods’ for pre-
cise genotype) in which the hematopoietic sys-
tem is labeled by Gal4-dependent expression of 
EGFP, such that it can be visualized in live, whole 
animals (Figure 2B–C). This line makes use of two 
gal4 drivers to target early lymph gland blood cells (hemocytes; Hand-gal4) and circulating and sessile 
blood cells (Hemolectin-gal4 or Hml-gal4) and incorporates a Gal4/FLP recombinase-dependent cell 
lineage tracing cassette to maintain Gal4 expression in the lymph gland after the Hand-gal4 driver 
itself is down-regulated during the first instar. The Hand-gal4 driver is expressed in the embryonic 
cardiogenic mesoderm from which the lymph gland is derived. Therefore, the dorsal vessel (heart) 
cardioblasts and the pericardial nephrocytes are also marked by the cell lineage tracing cassette 
(Figure 2B). EGFP is not expressed in other larval tissues, except in the late third-instar salivary glands 
that are readily discernible from the hematopoietic system (Figure 2B,E).
Figure 1. Equilibrium signaling maintains hematopoi-
etic progenitors in the developing lymph gland. The 
lymph gland primary lobe consists of three distinct 
cellular populations or zones. The medullary zone (MZ) 
contains blood progenitor cells while the nearby 
cortical zone (CZ) contains differentiating and mature 
blood cells. The posterior signaling center (PSC) 
functions as a supportive population (a niche) that 
expresses Hedgehog (Hh) and maintains the progenitor 
cells utilizing this ‘niche signal’. The receptor tyrosine 
kinase (RTK) Pvr and the STAT (STAT92E) transcriptional 
activator are required in CZ cells for the proper 
expression and secretion of the extracellular enzyme 
ADGF-A, which keeps the extracellular adenosine levels 
relatively low by converting it to inosine. The Pvr ligand 
Pvf1 is made in PSC cells and is transported through the 
lymph gland to activate Pvr in CZ cells. Collectively, we 
refer to the system that generates ADGF-A from the 
differentiating cells as ‘equilibrium signaling’, which is 
required independently of the niche-derived Hh 
signaling for the maintenance of progenitor blood cells 
in the MZ. Signaling events downstream of both 
ADGF-A and Hh (dashed arrows) cause the inhibition of 
Protein Kinase A (PKA) within progenitor blood cells, 
thereby promoting their maintenance. The individual 
components are color coded to match the schematic of 
the lymph gland. The equilibrium signal ADGF-A is blue, 
originating from the CZ; the niche signal Hh is magenta, 
originating in the PSC; PKA is gray, functioning in the 
MZ progenitor cells. Full details of this molecular 
pathway can be found in Mondal et al., (2011).
DOI: 10.7554/eLife.03626.003
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Figure 2. The Hand-Hemolectin Lineage Tracing-gal4 line (HHLT-gal4 UAS-2XEGFP) and its use as an in vivo 
screening tool. (A) Schematic describing the key elements of the HHLT-gal4 driver line. (B) Image showing the 
hematopoietic system within a wandering stage third-instar HHLT > GFP larva (dorsal view). Primary, secondary,  
and tertiary lobes of the lymph gland are readily discernible through overlying musculature, epidermal cells, and 
cuticle. Lymph gland lobes develop bilaterally, flanking the larval heart (dorsal vessel, DV). Non-blood pericardial 
cells (PC) also express GFP due to early expression of Hand-gal4. Circulating/sessile blood cells also express GFP 
due to Hml-gal4 and sessile groups are easily observable. GFP is also seen in ventrally located salivary glands  
(SG, out of focus) of larvae beyond the third-instar transition (due to Hand-gal4). (C) HHLT > GFP control larvae;  
(D) HHLT > GFP larvae overexpressing Ras85D (LA 527) exhibit hyperproliferative lymph glands; (E) HHLT > GFP 
larvae overexpressing combgap (LA 630) show little or no GFP expression in the lymph gland region. Arrows 
indicate GFP fluorescence from salivary glands (SG).
DOI: 10.7554/eLife.03626.004
The following figure supplement is available for figure 2:
Figure supplement 1. As a ‘proof-of-principle’ approach and to assess the effectiveness of HHLT-gal4 as a 
screening tool, HHLT-gal4 was crossed to lines harboring gain-of-function UAS transgenes known to cause 
excessive cellular proliferation, with the expectation that such transgenes would cause significant expansion of the 
hematopoietic tissues. 
DOI: 10.7554/eLife.03626.005
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Screening for progenitor maintenance genes in the developing  
lymph gland
A screen was conducted in which HHLT-gal4 was used to independently misexpress 503 unique UAS-
controlled Drosophila genes, with their effects on the hematopoietic system assessed in whole 
animals based upon EGFP expression. The particular collection of UAS-based gene misexpression 
lines used (termed LA lines) are mapped insertions (against Flybase release 5.7) of the P{Mae-
UAS.6.11} element into endogenous gene loci that have been previously shown to cause develop-
mental phenotypes upon misexpression (Crisp and Merriam, 1997; Bellen et al., 2004). When 
crossed to HHLT-gal4, 281 of these lines cause a scorable phenotype in either lymph glands or 
circulating blood cells of late third-instar larvae (Supplementary file 1). As an example, LA line 527, 
which is predicted to misexpress Ras85D, causes a robust expansion of the lymph gland (Figure 2D), 
consistent with the previously identified role of Ras85D in controlling hemocyte proliferation (Asha 
et al., 2003; Sinenko and Mathey-Prevot, 2004). By contrast, LA line 630 misexpresses the gene 
combgap (encoding a zinc finger transcription factor) and causes a strong reduction in lymph gland 
size (Figure 2E).
We used these results from the misexpression screen as a means to select potentially relevant 
genes for the subsequent loss-of-function analyses by RNA interference (using UAS-RNAi lines). We 
were able to obtain RNAi lines targeting 251 of the candidate genes identified by misexpression and 
found that 73 RNAi lines targeting 69 genes alter lymph gland size or morphology when crossed to 
HHLT-gal4 (Supplementary file 2).
To characterize the RNAi phenotypes in more detail, the level of blood cell differentiation 
within the lymph gland was evaluated by immunostaining with anti-Peroxidasin (Pxn) antibodies 
(Nelson et al., 1994). In wild-type lymph glands, expression of mature cell markers such as Pxn is 
restricted to the periphery of the primary lobe (the cortical zone) (Jung et al., 2005). By contrast, 
when niche signaling or equilibrium signaling are compromised, progenitor cells are lost and dif-
ferentiation markers, including Pxn, are expressed throughout the lymph gland primary lobes 
(Mandal et al., 2007; Mondal et al., 2011). Rescreening the 73 identified RNAi lines using HHLT-
gal4 identified 20 genes (21 RNAi lines) that, when knocked down, cause the expression of Pxn in 
cells throughout the lymph gland primary lobe (Figure 3; Table 1 and Supplementary file 2). 
Compared to controls, the progenitor population (Pxn negative) is either strongly reduced or absent 
in each RNAi background. This ‘expanded’ Pxn phenotype is interpreted as a loss-of-progenitor cell 
phenotype.
Zone-specific screening identifies putative equilibrium signaling genes
Using the pan-lymph gland HHLT-gal4 driver, we identified 21 RNAi lines that cause a loss of pro-
genitor cells in the primary lobes at late stages of lymph gland development. In order to discern 
whether any of the associated candidate genes have a specific progenitor-maintenance function 
that is restricted to cells belonging to a single zone, we rescreened the 21 RNAi lines using cell-
type-specific Gal4-expressing lines. Targeting RNAi to differentiating and mature cells using Hml-
gal4 (Sinenko and Mathey-Prevot, 2004) identified six genes (CG6854 [CTPsyn], CG7398 
[Transportin], CG7574 [bip1], CG10009 [Noa36], CG10198 [Nup98, also known as Nup98-96], and 
CG31938 [Rrp40]) that cause an expansion of Pxn (Figure 4A–G) and Hml-gal4, UAS EGFP (Figure 
4H–M) expression. Since the function of these genes is needed in the CZ for the maintenance of 
the MZ progenitors, these six genes encode likely candidates for new components of the equilib-
rium signaling pathway.
Screening with dome-gal4 (Jung et al., 2005) to target RNAi to the progenitor cells identified 
eleven genes (Figure 4—figure supplement 1A–L), three of which (Transportin, Noa36, and 
Rrp40) are in common with those identified using Hml-gal4. By contrast, use of Antennapedia-gal4 
(Antp-gal4) (Mandal et al., 2007) to target RNAi specifically to niche cells failed to identify any of 
the 21 lines as additional niche signaling components (not shown). Lastly, seven of the 21 RNAi 
lines did not cause a phenotype when expressed with any of the zone-specific Gal4 driver lines 
used. Taken together, our screen identified three genes, CTPsyn, bip1, and Nup98, which cause a 
loss of lymph gland progenitor cells upon RNAi knock down in differentiating cells, but not in 
progenitor cells or in niche cells. As described below, it was ultimately possible to connect two of 
these genes, bip1 and Nup98, to the equilibrium signaling pathway through the control of Pvr 
expression.
Developmental biology and stem cells
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The bip1 gene functions in differentiating cells to regulate progenitor 
maintenance
The bip1 gene was originally identified through a yeast two-hybrid screen that showed that its encoded 
protein binds the BTB/POZ domain of the transcription factor Bric à brac 1 (Bab1) (Pointud et al., 
2001), a protein that has several developmental roles including the formation of ovarian terminal fila-
ment cells that are required for germline stem cell maintenance (Lin and Spradling, 1993; Sahut-
Barnola et al., 1995; Couderc et al., 2002). Analysis of the predicted Bip1 amino acid sequence 
(InterPro) (Hunter et al., 2012) identifies a THAP domain containing a C2CH-type zinc finger motif 
that is known to bind DNA (Sabogal et al., 2010).
As no known bip1 mutants exist, several different approaches were used to validate the bip1 
RNAi results and elucidate the function of the bip1 gene in differentiating the blood cells. First, qRT-
PCR confirmed that bip1 is expressed in the lymph gland and demonstrated that the bip1 RNAi line 
(NIG 7574R-2) actually targets bip1 transcripts. Indeed, RNAi knock down of bip1 using Hml-gal4 
(Sinenko and Mathey-Prevot, 2004; Jung et al., 2005) reduces bip1 mRNA levels in the lymph 
gland to approximately ten percent of that observed in controls (Figure 5A). The bip1 RNAi blood 
phenotype is also suppressible by the simultaneous overexpression of bip1 (UAS-bip1LA645; Figure 
5B–B'), demonstrating the specific requirement for bip1 in maintaining progenitors. Driving bip1 
RNAi with Pxn-gal4, an alternative differentiating- and mature-cell driver to Hml-gal4, also causes 
the loss of progenitor cells (Figure 5C–C′), thereby confirming that bip1 knock-down in differentiat-
ing cells is key to its associated phenotype. Additionally, the progenitor cell marker dome-MESO-
lacZ (Hombria et al., 2005; Krzemien et al., 2007) is strongly reduced relative to control lymph 
glands (Figure 5D–D′) in the bip1 RNAi (Hml-gal4) background. This result confirms that progenitor 
cells fail to be maintained in bip1 RNAi lymph glands, rather than ectopically upregulating Pxn and 
Hml-gal4 expression.
Figure 3. Identification of RNAi lines that cause an expanded Peroxidasin phenotype when expressed throughout 
the lymph gland. Peroxidasin (Pxn, red) is normally restricted to cortical zone cells (near the periphery) (A, control) 
but is seen throughout the lymph gland in RNAi backgrounds (B–V) expressed by HHLT-gal4. Line identifiers and 
gene targets are shown; additional details listed in Table 1. Images represent a single middle confocal section 
taken from a Z-plane series through the entire primary lobe.
DOI: 10.7554/eLife.03626.006
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Several ribosomal components, including Ribosomal protein S8 (RpS8), have been shown to asso-
ciate with chromatin at active transcription sites and to associate with nascent transcripts to form 
ribonucleoprotein complexes (Brogna et al., 2002). Interestingly, RpS8 has also been identified in 
genomic-scale yeast two-hybrid analyses as a Bip1-interacting protein (Giot et al., 2003; Formstecher 
et al., 2005; Stark et al., 2006), which suggests that Bip1 and RpS8 may function together in vivo 
to regulate gene expression. Consistent with this idea, RNAi knockdown of RpS8 also causes the 
expanded expression of both Pxn and Hml-gal4 UAS-GFP expression throughout the lymph gland 
primary lobes (Figure 5E–E′). This result reflects a specific function of RpS8 in these cells because 
knockdown directly in niche or progenitor cells (using Antp-gal4 and dome-gal4, respectively) does 
not cause their loss to differentiation (not shown). Thus, RpS8 RNAi effectively phenocopies bip1 
RNAi, as both cause a loss of progenitor cells when knocked down in differentiating cells. Collectively, 
these data support a model in which Bip1 functions along with RpS8 in a protein complex within 
differentiating cells to maintain multipotent lymph gland progenitors at later stages of development, 
consistent with a potential function in the equilibrium signaling pathway.
bip1 functions genetically upstream of the equilibrium signaling 
pathway
The progenitor maintenance function of Pvr signaling in differentiated cells requires the downstream 
function of the STAT transcriptional activator and the secreted enzyme ADGF-A (Mondal et al., 2011), 
Table 1. RNAi lines and target genes causing an ‘expanded’ Peroxidasin expression phenotype with 
HHLT-gal4




targets LG size/quality Protein function
1 3859 CG4214 Syx5 0 Small/missing Golgi SNARE
2 6543 CG7398 Trn 1 Large/baggy hnRNP nuclear import
3 9572 CG5738 lolal 0 Small Transcription factor
4 12574 CG12052 lola 0 Large/baggy Transcription factor
5 12759 CG6854 CTPsyn 0 Small/baggy CTP synthase
6 15886 CG6376 E2f 1 Small/normal Transcription factor
7 17954 CG10009 Noa36 0 Small/missing Zinc finger nucleolar 
protein
8 19485 CG10009 Noa36 0 Small/missing Zinc finger nucleolar 
protein
9 22836 CG10267 Zif 0 Small/missing Transcription factor
10 24215 CG8149 CG8149 0 Baggy DNA binding protein
11 26176 CG3363 CG3363 0 Small Unknown
12 26370 CG4036 CG4036 1 Large Oxidoreductase
13 38472 CG1129 CG1129 0 Small/missing Peptide transferase
14 40306 CG31938 Rrp40 0 Small/normal RNA exosome
15 41009 CG3836 stwl 0 Small/normal Transcription factor
16 44606 CG6778 Aats-gly 0 Small/missing Glycyl-tRNA synthetase
17 49753* CG33155 CG33155 4 Small/normal Unknown
18 7574R-2 CG7574 bip1 0 Small/baggy Transcription factor
19 10198R-1 CG10198 Nup98-96 0 Small/missing Nucleoporin
20 12030R-2 CG12030 Gale 0 Small UDP-galactose 
4'-epimerase
21 12765R-3 CG12765 fsd 0 Small/normal F-box protein
*This RNAi line targeting sequence overlaps with the putative mRpL53 gene in the same locus. Lines 1–17 from 
VDRC, lines 18–21 from NIG Japan.
DOI: 10.7554/eLife.03626.007
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and, consistent with this relationship, overexpression of either activated STAT (STATACT) (Ekas et al., 
2010) or ADGF-A in differentiating cells can suppress the Pvr loss-of-function phenotype (Mondal et al., 
2011). Likewise, we find that overexpression of STATACT or ADGF-A can suppress the bip1 RNAi pheno-
type (Figure 6A–D′). Furthermore, overexpression of Pvr also strongly suppresses the bip1 RNAi pheno-
type, returning lymph gland morphology and organization to essentially wild type (Figure 6E–E′). 
By contrast, overexpression of bip1 does not suppress the Pvr RNAi phenotype (Hml-gal4 UAS-Pvr RNAi 
UAS-bip1LA645; not shown). Collectively, these results place bip1 function genetically upstream of Pvr and 
other equilibrium signaling components in lymph gland progenitor maintenance by differentiating cells.
Bip1 and RpS8 control the equilibrium signaling pathway by regulating 
Pvr expression
The suppression of the bip1 RNAi phenotype by overexpression of Pvr suggested that bip1 may pos-
itively control Pvr expression during normal development. Indeed, a reduction in Pvr protein expres-
sion within the lymph gland is observed in the bip1 RNAi background by mid-second instar, soon after 
differentiation begins (∼40 hr post-hatching; Figure 6F–J′). This reduction in Pvr expression is even 
stronger (along with significantly increased differentiation, based upon Hml-gal4 expression) at the 
same developmental time point in larvae having two copies of Hml-gal4 UAS-bip1 RNAi (compare 
Figure 6I′ with Figure 6H′), further supporting the model that bip1 RNAi causes the loss of Pvr expres-
sion. By the late third instar (when the bip1 RNAi differentiation phenotype is most apparent), Pvr 
protein levels in the lymph gland remain strongly reduced (Figure 6J–J′).
Knockdown of bip1 function in lymph glands by Hml-gal4-mediated RNAi reduces lymph gland Pvr 
transcript levels to approximately 70% of control levels (assessed by qRT-PCR; Figure 6—figure 
supplement 1A), consistent with the observed loss of Pvr protein (Figure 6H′–J′). However, because 
not all lymph gland cells express Hml (Hml-gal4), the actual reduction of Pvr transcript levels in cells 
expressing bip1 RNAi is likely to be greater than the observed total reduction. In support of this idea, 
Figure 4. Identification of candidate genes that cause an expanded Peroxidasin expression phenotype within the lymph gland when knocked down by 
RNAi in differentiating and mature cells. RNAi from identified lines (Figure 3/Table 1) was expressed in lymph glands using Hml-gal4 UAS-GFP (Hml > GFP). 
In the control, Pxn (A) and GFP (A′) are restricted to the cortical zone (periphery). By contrast, knock down of six candidate genes causes extensive expression 
of Pxn (B–G) and Hml (Hml > GFP) (B′–G′) throughout the lymph gland, indicating a loss of progenitors in these genetic backgrounds. The combined Pxn 
and Hml expression patterns for each genetic background are shown (MERGE, A″–G″). DNA (blue) is stained to mark nuclei.
DOI: 10.7554/eLife.03626.008
The following figure supplement is available for figure 4:
Figure supplement 1. RNAi lines causing an expanded Peroxidasin expression phenotype when expressed in progenitor cells using dome-gal4. 
DOI: 10.7554/eLife.03626.009
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bip1 RNAi in circulating blood cells (where greater than 90% express Hml-gal4) reduces Pvr transcript 
level to approximately 35% of the control level (Figure 6—figure supplement 1B). Expression of bip1 
RNAi in FLP-out Gal4-expressing cell clones made exclusively in the lymph gland strongly reduces Pvr 
levels compared to nearby cells not expressing RNAi as well as to mock clones (Figure 6—figure sup-
plement 2A–C), consistent with the autonomous regulation of Pvr by bip1 in the lymph gland. 
Furthermore, bip1 RNAi expression with srpHemo-gal4 (Bruckner et al., 2004), which expresses in a 
large fraction of circulating cells but in few or no cells within the lymph gland, does not reduce lymph 
gland Pvr levels (Figure 6—figure supplement 2E–H). Collectively, these data indicate that bip1 is 
required for proper Pvr protein expression, and therefore proper equilibrium signaling, within the 
developing lymph gland.
As described above, RpS8 is a putative Bip1-interacting protein in vivo and RpS8 RNAi in differen-
tiating lymph gland cells, like bip1 RNAi, causes the loss of progenitor cells (Figure 5F–F′). This effect 
is likely due to the loss of equilibrium signaling during development since RpS8 RNAi also reduces Pvr 
protein expression in the lymph gland (Figure 6K–K′). Knockdown of RpS8 by RNAi, as with knock-
down of bip1, also reduces Pvr transcript levels (Figure 6—figure supplement 1C). Interestingly, a 
Drosophila RNAi screen using the blood-related S2 cell line previously identified both Pvr and RpS8 as 
regulators of cell size and division (Sims et al., 2009). Although the relationship between Pvr and RpS8 
was not explored, their results as well as ours are consistent with RpS8 having a regulatory role in Pvr 
expression in blood cells.
Nup98 also regulates Pvr expression
In addition to bip1, the screen described here identified Nup98 as a potential equilibrium signaling 
component because its knockdown in differentiating cells specifically causes a loss of progenitors cells 
(Figure 3T and Figure 4F–F′′). Although Nup98 is widely known as a general component of the 
nuclear pore complex, recent work has demonstrated that Nup98 and other nuclear pore components 
such as Sec13 and Nup88, can regulate gene expression through the binding of target promoters 
(Capelson et al., 2010; Kalverda et al., 2010; Liang et al., 2013). Moreover, chromatin immunopre-
cipitation experiments identified bip1, RpS8, and the equilibrium signaling genes Pvr and STAT 
(STAT92E) as in vivo Nup98 regulatory targets (Capelson et al., 2010). Consistent with a function in 
regulation of equilibrium signaling genes, Nup98 knockdown specifically in differentiating cells of 
lymph glands causes a strong reduction in Pvr expression (Figure 6L–L′). By contrast, RNAi knockdown 
Figure 5. Validation of the bip1 RNAi phenotype. (A) Quantitative RT-PCR demonstrates that bip1 is expressed in the lymph gland and that the RNAi line 
NIG 7574R-1 targeting bip1 indeed reduces bip1 transcript level when expressed using Hml-gal4. Hml-gal4 expresses GFP throughout the primary lobes 
in bip1 RNAi lymph glands (Hml > bip1-i, B), and this phenotype is suppressed by overexpression of bip1 (B′), restoring both the cortical and the medullary 
zones. (C–C′) Expression of bip1 RNAi using Pxn-gal4 phenocopies obtained with Hml-gal4, further supporting a cell-type-specific function of bip1. 
Expression of the progenitor cell marker dome-MESO-lacZ (D) is strongly reduced in bip1 RNAi lymph glands (D′), demonstrating that the gain in differentiation 
markers is due to the loss of progenitor cells that normally express dome-MESO-lacZ. RNAi knock down of RpS8, encoding a putative Bip1-interacting 
protein, causes the expansion of Pxn and Hml-gal4 expression throughout the lymph gland (E–E′), similar to that observed upon the loss of bip1.
DOI: 10.7554/eLife.03626.010
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Figure 6. bip1, RpS8, and Nup98 control Pvr expression in the lymph gland. Expression of bip1 RNAi in differentiating 
cells (Hml-gal4 or Hml>, B–B′) causes expansion of both Pxn and Hml-gal4 UAS-GFP throughout the lymph gland, 
as compared to controls (A–A′). Misexpression of either activated STAT (STATACT, C–C′), ADGF-A (D–D′), or Pvr 
(E–E′) partially (in the case of STAT activation or ADGF-A overexpression) or fully (in case of Pvr overexpression) 
suppresses this bip1 phenotype, suggesting that bip1 functions upstream of these genes. Expression of Pvr in 
control third-instar lymph glands (F–F′) and mid-second instar (40 hr post-hatching, G–G′). Reduced expression of 
Pvr is already apparent in bip1 RNAi lymph glands by 40 hr (H–H′), and this loss is even stronger in homozygous 
animals expressing higher levels of RNAi (I–I′); increased differentiation, based upon Hml-gal4 UAS-GFP 
expression, is also apparent (I). Strong suppression of Pvr is also observed in homozygous bip1 RNAi lymph 
glands (J–J′). RNAi knockdown of RpS8 also causes differentiation and the loss of Pvr expression (K–K′). 
Likewise, RNAi knockdown of Nup98 also causes differentiation and the loss of Pvr expression (L–L′). (M) Control 
background (Hml-gal4/+) showing normal expression of the differentiation marker Pxn in the cortical zone of the 
lymph gland. Progenitor cells in the MZ region are easily discerned by their lack of Pxn expression. By contrast, few 
progenitor cells (Pxn-negative cells) are observed in lymph glands when single-copy loss-of-function mutations of 
Figure 6. Continued on next page
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of the nucleoporin Sec13 in differentiating cells has no effect on the maintenance of progenitor cells 
or Pvr expression (Figure 6—figure supplement 3) underscoring the specific role of Nup98 in Pvr 
expression control. Furthermore, the close genetic relationship between Nup98 and Pvr is illustrated 
by the fact that single-copy loss of these genes in combination causes extensive loss of progenitor 
cells to differentiation (Figure 6M–M′). Interestingly, overexpression of bip1 in Nup98 RNAi lymph 
glands (Hml-gal4 UAS-Nup98 RNAi UAS-bip1LA645) is sufficient to restore Pvr protein expression and to 
suppress the loss of progenitors to differentiation (based upon lymph gland morphology and Hml-gal4 
expression; Figure 6N–N′).
As has been shown, knockdown of bip1, Nup98, or RpS8 in differentiating cells each causes a 
strong reduction in Pvr expression in the lymph gland. Our interpretation of this common phenotype 
is that each gene works in the equilibrium signaling pathway to control Pvr expression, although an 
alternative hypothesis is that the loss of Pvr expression is a common feature of highly differentiated 
lymph glands and is not specifically related to the function of these genes. To test this, Pvr expression 
was examined in collier (col) mutant lymph glands, which lack niche signaling and are strongly differ-
entiated by late larval stages (Crozatier et al., 2004; Mandal et al., 2007), and was found to be 
normal (Figure 6—figure supplement 4, compare with Pvr expression in wild-type cortical zone dif-
ferentiating cells in Figure 6F′). Thus, Pvr requires bip1, RpS8, and Nup98 for proper developmental 
expression in the lymph gland.
Several genetic screens, including overexpression and enhancer/suppressor screens of mutant or 
tumor phenotypes, have been conducted in the fly hematopoietic system (Milchanowski et al., 2004; 
Zettervall et al., 2004; Stofanko et al., 2008; Avet-Rochex et al., 2010; Tan et al., 2012; Tokusumi 
et al., 2012); however, the screen described here represents the first loss-of-function screen targeting 
normal developmental mechanisms throughout the lymph gland. This was accomplished with the 
development and use of the pan-lymph gland expression tool HHLT-gal4 to drive UAS-mediated RNAi, 
which identified 20 different candidate genes that cause a loss of progenitor cells when knocked down 
within the lymph gland. From subsequent analyses using lymph gland zone-restricted Gal4 driver lines, 
we arrive at a model (Figure 7) in which Bip1, RpS8, and Nup98 are required in differentiating blood 
cells upstream of Pvr to control its expression and function in the equilibrium signaling pathway that 
maintains blood progenitors within the lymph gland. Future analyses will be required to identify addi-
tional components of this important signaling pathway and to provide more information about how 
equilibrium signaling interacts with other pathways in the control of blood cell progenitor mainte-
nance, cell fate specification, and proliferation.
The Pvr receptor, with its numerous developmental roles, is arguably one of the most important 
members of the Drosophila RTK family, yet most of what is known about Pvr stems from analyses of 
how it works in the context of intracellular signaling. Little is known about how Pvr gene or protein 
Pvr and Nup98 (PvrC2195/+; Nup98Df(3R)mbc-R1/+) are combined (M′), further indicating the close interaction between 
these genes. The middle-third (confocal z-stack) of the primary lobe is shown. Misexpression of bip1 in this 
background is sufficient to suppress these phenotypes and restore Pvr expression to the lymph gland (N–N′).
DOI: 10.7554/eLife.03626.011
The following figure supplements are available for figure 6:
Figure supplement 1. bip1 and RpS8 are required for normal Pvr transcript levels. 
DOI: 10.7554/eLife.03626.012
Figure supplement 2. Pvr expression is regulated autonomously by bip1, Nup98, and RpS8 within the lymph 
gland. 
DOI: 10.7554/eLife.03626.013
Figure supplement 3. Loss of the nucleoporin Sec13 by RNAi neither causes a differentiation phenotype within the 
lymph gland nor the loss of Pvr expression. 
DOI: 10.7554/eLife.03626.014
Figure supplement 4. Loss of Pvr expression is not a common feature of highly differentiated lymph glands. 
DOI: 10.7554/eLife.03626.015
Figure supplement 5. Overexpression of bip1, Nup98, and RpS8, and RNAi knockdown of other nucleoporins 
does not affect Pvr levels in the lymph gland. 
DOI: 10.7554/eLife.03626.016
Figure 6. Continued
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expression is regulated. Importantly, the work 
described here sheds new light upon this issue by 
demonstrating a role for bip1, RpS8, and Nup98 
in the regulation of Pvr expression. Our data and 
that of others suggest that this regulation of Pvr 
is likely taking place at the gene level, although 
other mechanisms are also possible. Ribosomes 
are required for protein translation, however 
specific ribosomal components or subunits may 
selectively stabilize transcripts and/or mediate 
preferential translation (Xue and Barna, 2012), 
while nucleoporins control both nuclear entry of 
regulatory proteins and the exit of mRNAs to 
the cytoplasm, and specific subcomponents are 
known to exhibit differential functions in this 
regard (Strambio-De-Castillia et al., 2010). Thus, 
RpS8 and Nup98 may selectively affect Pvr  
expression post-transcriptionally through transcript 
stabilization, transport, and translation. Although 
the specific mechanisms of molecular control of 
Pvr expression by bip1, RpS8, and Nup98 remain 
to be determined, their function is clearly critical 
in mediating proper equilibrium signaling and, 
therefore, proper blood progenitor maintenance 
within the lymph gland. The finding that bip1 
regulates Pvr expression in the context of hema-
topoietic equilibrium signaling represents the 
first functional association for bip1 in Drosophila. 
The predicted Bip1 protein exhibits only one rec-
ognizable structural sequence, namely a THAP 
domain that contains a putative DNA-binding 
zinc finger motif. Our results suggest that Bip1 
behaves as a positive regulator of Pvr transcrip-
tion, but whether this occurs directly through 
Bip1 interaction with the Pvr locus will require fur-
ther investigation.
Understanding how progenitor cell maintenance 
and homeostasis is controlled over developmen-
tal time is crucial for understanding normal cel-
lular and tissue dynamics, especially in the context 
of ageing or disease. The identification of Bip1 
and Nup98 as regulators of hematopoietic pro-
genitors in Drosophila may be indicative of important conserved functions of related proteins within 
the vertebrate blood lineages similar to what has been shown previously for GATA, FOG, and RUNX 
factors (Waltzer et al., 2010). THAP-domain proteins are conserved across species and have been 
reported to have a variety of important functions in mammalian systems, including maintenance of 
murine embryonic stem cell pluripotency (Cayrol et al., 2007; Dejosez et al., 2008, 2010). What role, 
if any, THAP-domain proteins have in vertebrate blood progenitor maintenance (or hematopoiesis in 
general) remains to be established. Likewise, Nup98 has not been implicated in any normal hemato-
poietic role despite being a well-studied protein in other contexts.
With regard to the diseased state, mutations in the human THAP1 gene have been associated 
with dystonia (Fuchs et al., 2009; Paisan-Ruiz et al., 2009; Kaiser et al., 2010; Mazars et al., 
2010), a neuromuscular disorder that causes repetitive, involuntary muscular contraction, and 
THAP1/Par4 protein complexes have been shown to promote apoptosis in leukemic blood cells in 
various experimental contexts in vitro (Lu et al., 2013; Zhang et al., 2014). Chromosomal transloca-
tions that generate Nup98 fusion proteins have been implicated in numerous human myelodysplastic 
Figure 7. Schematic of the equilibrium signaling 
pathway demonstrating the proposed roles of Bip1, 
RpS8, and Nup98 in controlling Pvr. Bip1, RpS8, and 
Nup98 are independently required for the expression of 
Pvr (direct arrows). Rescue of endogenous Pvr expres-
sion by misexpression of bip1 in the Nup98 RNAi 
background indicates that bip1 functions genetically 
downstream of Nup98 (dashed arrow) in the control of 
Pvr expression. Bip1 and RpS8 may work together in a 
complex (dashed line) to control Pvr expression in vivo. 
These components collectively comprise the known 
equilibrium signaling pathway working within the lymph 
gland to promote progenitor cell maintenance, along 
with the previously known Hh niche signaling 
mechanism.
DOI: 10.7554/eLife.03626.017
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syndromes and leukemias (Nishiyama et al., 1999; Ahuja et al., 2001; Lin et al., 2005; Nakamura, 
2005; van Zutven et al., 2006; Slape et al., 2008; Kaltenbach et al., 2010; Murayama et al., 2013), 
further underscoring the need to explore Nup98 function in the hematopoietic system. Therefore, the 
study of bip1 and Nup98 in Drosophila, a powerful molecular genetic system, will likely be of benefit 
to understand the function of related vertebrate genes in normal and disease contexts.
Materials and methods
Fly stocks
Misexpression P{Mae-UAS.6.11} inserts (LA lines) were obtained from John Merriam, UCLA 
(Los Angeles, California). UAS-RNAi lines were obtained from the Vienna Drosophila RNAi Center 
(VDRC, Vienna, Austria), the National Institute of Genetics (NIG, Kyoto, Japan), and the Bloomington 
Drosophila Stock Center (TRiP lines, BDSC, Bloomington, Indiana). The lines UAS-FLP.JD1, UAS-
2XEGFP, P{GAL4-Act5C(FRT.CD2).P}S, UAS-human RafACT, Df(3R)mbc-R1, UAS-RpS8PD01446, and w1118 
(BDSC 5905) were from the BDSC. Pvrc02195 was from Exelixis (available from BDSC, obtained from D 
Montell). HmlΔ-gal4 UAS-2XEGFP (S Sinenko), Antp-gal4/TM6B Tb (S Cohen), P{ubi-gal80 ts}10; 
Antp-gal4/TM6B Tb (this lab), domeless-gal4 UAS-2XEYFP/FM7i (this lab), UAS-DAlkACT (R Palmer), 
dome-MESO-lacZ (S Brown), Pxn-gal4 (M Galko), UAS-STATACT (E Bach), UAS-ADGF-A (T Dolezal), 
collier1; P(col5-cDNA)/CyO-TM6B, Tb (M Crozatier), srpHemo-gal4 (K Brückner), and Hand-gal4  
(Z Han) have been previously described.
HHLT-gal4 construction and whole animal screening
Second chromosome inserts of Hand-gal4, HmlΔ-gal4, UAS-FLP.JD1, and UAS-2XEGFP were recom-
bined onto a single chromosome and placed with P{GAL4-Act5C(FRT.CD2).P}S on Chromosome 3. 
Because Gal4 reporter lines with specific, pan-lymph gland expression are unknown, we took advan-
tage of a FLP-out lineage tracing approach that we have used previously to perpetually mark lymph 
gland cells (Jung et al., 2005; Evans et al., 2009). The Hand-gal4 reporter reflects the expression of 
the Hand gene, which is expressed in the cardiogenic mesoderm, from which the lymph gland is 
derived. Within the lymph gland, Hand-gal4 is expressed from the late embryo through the first larval 
instar but then is downregulated (Han and Olson, 2005). Using Hand-gal4 in conjunction with UAS-
FLP and a FLP-out Gal4-expressing line (P{GAL4-Act5C(FRT.CD2).P}S) (Pignoni and Zipursky, 1997), 
lymph gland cells are perpetually with EGFP throughout all subsequent developmental stages. To 
express EGFP in circulating cells, we used Hemolectin-gal4 (HmlΔ-gal4) (Sinenko and Mathey-Prevot, 
2004), which is specific to mature blood cells both in circulation and in the lymph gland cortical zone 
(Jung et al., 2005). HHLT-gal4 expression is easily detectable in lymph glands and circulating cells of 
whole animals throughout larval development. Due to the embryonic activity of Hand-gal4, HHLT-gal4 
also labels dorsal vessel cardioblasts and pericardial cells, although by late larval stages the expression 
of EGFP in the former is almost undetectable.
HHLT-gal4 virgins were crossed to males from individual LA lines, RNAi lines, or w1118 as a control. 
All crosses were reared at 29°C to maximize Gal4 activity. Wandering third-instar larvae from control 
and experimental crosses were collected, washed with water, and placed in glass spot wells (Fisher) on 
ice to minimize movement. Animals were scored visually using a Zeiss Axioskop 2 compound fluores-
cence microscope. Non-screen images of HHLT > GFP larvae were collected with a Zeiss SteREO 
Lumar fluorescence microscope. Images were collected using either an AxioCam HRc or HRm camera 
with AxioVision software.
Tissue dissection and antibody staining and analysis
Lymph glands were dissected and processed as previously described (Jung et al., 2005). Briefly, lymph 
glands were dissecting from third-instar larvae in 1× PBS, fixed in 4% formaldehyde/1× PBS for 30 min, 
washed three times in 1×PBS with 0.4% Triton-X (1× PBST) for 15 min each, blocked in 10% normal 
goat serum/1× PBST for 30 min, followed by incubation with primary antibodies in block. Primary 
antibodies were incubated with tissue overnight at 4°C and then washed three times in 1× PBST for 
15 min each, reblocked for 15 min, followed by incubation with secondary antibodies for 3 hr at room 
temperature. Samples were washed three times in 1× PBST, with TO-PRO-3 iodide (diluted 1:1000; 
Invitrogen, Carlsbad, California) added to the last wash to stain nuclei. Samples were washed briefly 
with 1× PBS to remove excess TO-PRO-3 and detergent prior to mounting on glass slides in VectaShield 
(Vector Laboratories, Burlingame, California). Mouse anti-Peroxidasin was a kind gift from John and 
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Lisa Fessler (UCLA) and was used at 1:1500 dilution. Rat anti-Pvr was a kind gift from Benny Shilo 
and was used at 1:400 dilution. Secondary Cy3-labeled antibodies were obtained from Jackson 
ImmunoResearch Laboratories Inc. (West Grove, Pennsylvania) and used at 1:500 dilution.
Quantitative real-time PCR analysis
Lymph glands from 50 third-instar larvae were isolated by dissection. For fat body analysis, ten third-instar 
larvae were used. RNA was extracted from these tissues with the RNeasy mini kit (Qiagen, Germantown, 
Maryland). Relative quantitative RT-PCR (comparative CT) was performed using Power SYBR Green RNA-
to-CT 1-step kit (Applied Biosystems, Carlsbad, California) and a StepOne Real-Time PCR detection 
thermal cycler (Applied Biosystems) using primers specific for Pvr, bip1, and rp49. Primer sequences are: 
Pvr(forward), 5′-TTCGGATTTCGATGGTGAAT-3′; Pvr(reverse), 5′-CGGACACTAAGCTGGTCGAT-3′; 
bip1(forward), 5′-CGGAGTTTATGGACAGCACA-3′; bip1(reverse), 5′-CCTTAGCAGGAGGAGGAGGT-3′; 
rp49(forward), 5′-GCTAAGCTGTCGCACAAATG-3′; rp49(reverse), 5′-GTTCGATCCGTAACCGATGT-3′.
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